Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Hybrid Capture HPV data

DIGE reported preliminary results from a trial using 46,000 Pap smears, in which its DNA test to detect HPV was able to reduce the rate of further, invasive testing. In the trial at Kaiser Foundation, reported

Read the full 362 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE